nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinoxacin—Abdominal cramps—Vincristine—lymphatic system cancer	0.0275	0.0275	CcSEcCtD
Cinoxacin—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0223	0.0223	CcSEcCtD
Cinoxacin—Tinnitus—Mechlorethamine—lymphatic system cancer	0.022	0.022	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.0199	0.0199	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.0169	0.0169	CcSEcCtD
Cinoxacin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Cinoxacin—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Cinoxacin—Anorexia—Mechlorethamine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Cinoxacin—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Cinoxacin—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Cinoxacin—Oedema—Teniposide—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Cinoxacin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Cinoxacin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Cinoxacin—Pruritus—Mechlorethamine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Cinoxacin—Anorexia—Teniposide—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Cinoxacin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Cinoxacin—Oedema—Fludarabine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Cinoxacin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Cinoxacin—Decreased appetite—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Cinoxacin—Vomiting—Mechlorethamine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Cinoxacin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Cinoxacin—Rash—Mechlorethamine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Cinoxacin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Cinoxacin—Anorexia—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Cinoxacin—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Cinoxacin—Nausea—Mechlorethamine—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Cinoxacin—Urticaria—Teniposide—lymphatic system cancer	0.00981	0.00981	CcSEcCtD
Cinoxacin—Abdominal pain—Teniposide—lymphatic system cancer	0.00976	0.00976	CcSEcCtD
Cinoxacin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00975	0.00975	CcSEcCtD
Cinoxacin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00944	0.00944	CcSEcCtD
Cinoxacin—Pain—Fludarabine—lymphatic system cancer	0.00928	0.00928	CcSEcCtD
Cinoxacin—Hypersensitivity—Teniposide—lymphatic system cancer	0.0091	0.0091	CcSEcCtD
Cinoxacin—Pruritus—Teniposide—lymphatic system cancer	0.00874	0.00874	CcSEcCtD
Cinoxacin—Diarrhoea—Teniposide—lymphatic system cancer	0.00845	0.00845	CcSEcCtD
Cinoxacin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Cinoxacin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00796	0.00796	CcSEcCtD
Cinoxacin—Oedema—Bleomycin—lymphatic system cancer	0.00796	0.00796	CcSEcCtD
Cinoxacin—Vomiting—Teniposide—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Cinoxacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00779	0.00779	CcSEcCtD
Cinoxacin—Rash—Teniposide—lymphatic system cancer	0.00779	0.00779	CcSEcCtD
Cinoxacin—Dermatitis—Teniposide—lymphatic system cancer	0.00778	0.00778	CcSEcCtD
Cinoxacin—Headache—Teniposide—lymphatic system cancer	0.00774	0.00774	CcSEcCtD
Cinoxacin—Pruritus—Fludarabine—lymphatic system cancer	0.00768	0.00768	CcSEcCtD
Cinoxacin—Anorexia—Bleomycin—lymphatic system cancer	0.00759	0.00759	CcSEcCtD
Cinoxacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00743	0.00743	CcSEcCtD
Cinoxacin—Nausea—Teniposide—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Cinoxacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Cinoxacin—Oedema—Carmustine—lymphatic system cancer	0.00695	0.00695	CcSEcCtD
Cinoxacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Cinoxacin—Vomiting—Fludarabine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Cinoxacin—Rash—Fludarabine—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Cinoxacin—Dermatitis—Fludarabine—lymphatic system cancer	0.00684	0.00684	CcSEcCtD
Cinoxacin—Pain—Bleomycin—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Cinoxacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Cinoxacin—Headache—Fludarabine—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Cinoxacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Cinoxacin—Oedema—Vincristine—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Cinoxacin—Anorexia—Carmustine—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Cinoxacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Cinoxacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Cinoxacin—Oedema—Mitoxantrone—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Cinoxacin—Nausea—Fludarabine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Cinoxacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Cinoxacin—Urticaria—Bleomycin—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Cinoxacin—Anorexia—Vincristine—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Cinoxacin—Insomnia—Carmustine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Cinoxacin—Paraesthesia—Carmustine—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Cinoxacin—Somnolence—Carmustine—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Cinoxacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Cinoxacin—Decreased appetite—Carmustine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Cinoxacin—Insomnia—Vincristine—lymphatic system cancer	0.006	0.006	CcSEcCtD
Cinoxacin—Paraesthesia—Vincristine—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Cinoxacin—Pain—Carmustine—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Cinoxacin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Cinoxacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00586	0.00586	CcSEcCtD
Cinoxacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Cinoxacin—Decreased appetite—Vincristine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Cinoxacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Cinoxacin—Pain—Vincristine—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Cinoxacin—Pruritus—Bleomycin—lymphatic system cancer	0.00563	0.00563	CcSEcCtD
Cinoxacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Cinoxacin—Eosinophilia—Methotrexate—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Cinoxacin—Pain—Mitoxantrone—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Cinoxacin—Abdominal pain—Carmustine—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Cinoxacin—Abdominal pain—Vincristine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Cinoxacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Cinoxacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Cinoxacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Cinoxacin—Vomiting—Bleomycin—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Cinoxacin—Drowsiness—Methotrexate—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Cinoxacin—Rash—Bleomycin—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Cinoxacin—Dermatitis—Bleomycin—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Cinoxacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.005	0.005	CcSEcCtD
Cinoxacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Cinoxacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Cinoxacin—Diarrhoea—Carmustine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Cinoxacin—Nausea—Bleomycin—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Cinoxacin—Dizziness—Carmustine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Cinoxacin—Diarrhoea—Vincristine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Cinoxacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Cinoxacin—Vomiting—Carmustine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Cinoxacin—Dizziness—Vincristine—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Cinoxacin—Rash—Carmustine—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Cinoxacin—Dermatitis—Carmustine—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Cinoxacin—Headache—Carmustine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Cinoxacin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Cinoxacin—Tinnitus—Methotrexate—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Cinoxacin—Vomiting—Vincristine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Cinoxacin—Rash—Vincristine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Cinoxacin—Dermatitis—Vincristine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Cinoxacin—Headache—Vincristine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Cinoxacin—Nausea—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Cinoxacin—Vomiting—Mitoxantrone—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Cinoxacin—Rash—Mitoxantrone—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Cinoxacin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Cinoxacin—Headache—Mitoxantrone—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Cinoxacin—Nausea—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Cinoxacin—Nausea—Mitoxantrone—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Cinoxacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Cinoxacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Cinoxacin—Anorexia—Methotrexate—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Cinoxacin—Insomnia—Methotrexate—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Cinoxacin—Paraesthesia—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Cinoxacin—Somnolence—Methotrexate—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Cinoxacin—Decreased appetite—Methotrexate—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Cinoxacin—Pain—Methotrexate—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Cinoxacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Cinoxacin—Urticaria—Methotrexate—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Cinoxacin—Abdominal pain—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Cinoxacin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Cinoxacin—Pruritus—Methotrexate—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Cinoxacin—Diarrhoea—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Cinoxacin—Dizziness—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Cinoxacin—Vomiting—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cinoxacin—Rash—Methotrexate—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cinoxacin—Dermatitis—Methotrexate—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cinoxacin—Headache—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Cinoxacin—Nausea—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
